This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (636) Cardiology (204) Descriptive Epidemiology and Population Size Estimates (122) Electronic Health Records (1210) Cardiac Risk and Cardiac Risk Calculators (76)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71314, first published .
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study

Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study

Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy: Protocol for a Multicountry Disease Registry Study

Authors of this article:

Yen-Hung Lin1, 2 Author Orcid Image ;   Hsu-Wen Chou3 Author Orcid Image ;   Sarah Tsai3 Author Orcid Image ;   Roy Gomez4 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Yen-Hung Lin   1, 2 , MD, PhD ;   Hsu-Wen Chou   3 , PhD ;   Sarah Tsai   3 , MSc ;   Roy Gomez   4 , PhD

1 Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

2 Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan

3 Medical Affairs, Pfizer Ltd., Taipei, Taiwan

4 Emerging Markets Asia Specialty Care, Global Medical Affairs, Pfizer Private Limited, Singapore, Singapore

Corresponding Author:

  • Roy Gomez, PhD
  • Emerging Markets Asia Specialty Care, Global Medical Affairs
  • Pfizer Private Limited
  • 80 Pasir Panjang Rd
  • #16-81/82 Mapletree Business City II
  • Singapore 117372
  • Singapore
  • Phone: 65 +65 6403 8888
  • Email: Roy.Gomez@pfizer.com